Skip to main content
SpringerLink
Log in

Long-Term Management of the Kidney Transplant Recipient

  • Chapter
  • First Online:
Transplantation Surgery

Part of the book series: Springer Specialist Surgery Series ((SPECIALIST))

  • 550 Accesses

Abstract

Due to the successes of kidney transplantation, patients are surviving long-term with their allografts. In addition to care of the allograft and administration of immunosuppressive medications, common medical conditions should be recognized and managed appropriately. With constraints on transplant centers and patient considerations of finance and geography, community providers will play an ever increasing role in the care of the kidney transplant recipient. Guidelines for understanding and managing common medical conditions as they relate to cardiovascular disease, chronic kidney disease, transplant related issues, and general health maintenance are reviewed in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. US Renal Data System 2017 annual data report: epidemiology of kidney disease in the United States. AJKD. 2018 Mar;71(3):S1–S676.

    Google Scholar 

  2. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999 Dec;341(23):1725–30.

    Article  CAS  PubMed  Google Scholar 

  3. Kasiske BL. Ischemic heart disease after renal transplantation. Kidney Int. 2002 Jan;61(1):356–69.

    Article  PubMed  Google Scholar 

  4. Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation. 2006 Sept;82(5):603–11.

    Article  PubMed  Google Scholar 

  5. Neale J, Smith AC. Cardiovascular risk factors following renal transplant. World J Transplant. 2015 Dec;5(4):183–95.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Campistol JM, Romero R, Paul J, Gutierrez-Dalmau A. Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade. Nephrol Dial Transplant. 2004 Jun;19(Suppl 3):iii62–6.

    PubMed  Google Scholar 

  7. Kasiske BL, Anjum S, Shah R, Skogen J, Kandaswamy C, Danielson B, et al. Hypertension after kidney transplantation. Am J Kidney Dis. 2004 Jun;43(6):1071–81.

    Article  PubMed  Google Scholar 

  8. Becker GJ, et al. Kidney disease: Improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Inter. 2012;2(Suppl):337–414.

    Google Scholar 

  9. Kobashigawa JA, Kasiske BL. Hyperlipidemia in solid organ transplantation. Transplantation. 1997 Feb;63(3):331–8.

    Article  CAS  PubMed  Google Scholar 

  10. Wanner C, Tonelli M, The Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members. KDIGO clinical practice guideline for lipid management in CKD: summary of recommendation statements and clinical approach to the patient. Kidney Int, 2014 Jun;85(6):1303–9.

    Google Scholar 

  11. Jardine AG, Holdaas H, Fellstrom B, Cole E, Nyberg G, Gronhagen-Riska C, et al. Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT study. Am J Transplant. 2004 Jun;4(6):988–95.

    Article  CAS  PubMed  Google Scholar 

  12. Kasiske B, Cosio FG, Beto J, Bolton K, Chavers BM, Grimm R Jr, et al. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the managing dyslipidemias in chronic kidney disease work group of the national kidney foundation kidney disease outcomes quality initiative. Am J Transplant. 2004;4(Suppl 7):13–53.

    Article  PubMed  Google Scholar 

  13. Puthenparumpil JJ, Keough-Ryan T, Kiberd M, Lawen J, Kiberd BA. Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population. Transplant Proc. 2005 Mar;37(2):1033–5.

    Article  CAS  PubMed  Google Scholar 

  14. Sharif A, Cohney S. Post-transplantation diabetes: state of the art. Lancet Diabetes Endocrinol. 2016 Apr;4:337349.

    Article  Google Scholar 

  15. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant. 2003 Feb;3(2):178–85.

    Article  PubMed  Google Scholar 

  16. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003 Jan;26(Suppl 1):S5–20.

    Google Scholar 

  17. Wilkinson A, Davidson J, Dotta F, Home PD, Keown P, Kiberd B, et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transpl. 2005 Jun;19(3):291–8.

    Article  Google Scholar 

  18. Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, et al. Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant. 2003 Jul;3(7):835–45.

    Article  PubMed  Google Scholar 

  19. Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, et al. Recommendations for the outpatient surveillance of renal transplant recipients. American society of transplantation. J Am Soc Nephrol. 2000 Oct;11(Suppl 15):S1–86.

    PubMed  Google Scholar 

  20. Blosser CD, Bloom RD. Posttransplant anemia in solid organ recipients. Transplant Rev (Orlando). 2010 Apr;24(2):89–98.

    Article  Google Scholar 

  21. Rigatto C. Anemia, renal transplantation, and the anemia paradox. Semin Nephrol. 2006 Jul;26(4):307–12.

    Article  PubMed  Google Scholar 

  22. KDIGO Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012 Aug;2(4):279–335.

    Article  Google Scholar 

  23. Naylor KL, Li AH, Lam NN, Hodsman AB, Jamal SA, Garg AX. Fracture risk in kidney transplant recipients: a systematic review. Transplantation. 2013 Jun;95(12):1461–70.

    Article  PubMed  Google Scholar 

  24. Versele EB, Van Laecke S, Dhondt AW, Verbeke F, Vanholder R, Van Biesen W, Nagler EV. Bisphosphonates for preventing bone disease in kidney transplant recipients: a meta-analysis of randomized controlled trials. Transplant Int. 2016 Feb;29(2):153–64.

    Article  CAS  Google Scholar 

  25. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant. 2004 Aug;4:1289–95.

    Article  PubMed  Google Scholar 

  26. Karthikeyan V, Karpinski J, Nair RC, Knoll G. The burden of chronic kidney disease in renal transplant recipients. Am J Transplant. 2004 Feb;4(2):262–9.

    Article  PubMed  Google Scholar 

  27. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol. 1999 Jan;10(1):167–81.

    CAS  PubMed  Google Scholar 

  28. Artz MA, Hilbrands LB, Borm G, Assmann KJ, Wetzels JF. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. Nephrol Dial Transplant. 2004 Nov;19(11):2852–7.

    Article  CAS  PubMed  Google Scholar 

  29. Lin J, Valeri AM, Markowitz GS, D'Agati VD, Cohen DJ, Radhakrishnan J. Angiotensin converting enzyme inhibition in chronic allograft nephropathy. Transplantation. 2002 Mar;73(5):783–8.

    Article  CAS  PubMed  Google Scholar 

  30. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med. 2003 Dec;349(24):2326–33.

    Article  CAS  PubMed  Google Scholar 

  31. Mulay AV, Hussain N, Fergusson D, Knoll GA. Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials. Am J Transplant. 2005 Jul;5(7):1748–56.

    Article  CAS  PubMed  Google Scholar 

  32. Mulay AV, Cockfield S, Stryker R, Fergusson D, Knoll GA. Conversion from calcineurin inhibitors to sirolimus for chronic renal allograft dysfunction: a systematic review of the evidence. Transplantation. 2006 Nov;82(9):1153–62.

    Article  PubMed  Google Scholar 

  33. Masso P, Henderson L, Chapman JR, Craig JC, Webster AC. Belatacept for kidney transplant recipients. Cochrane Database Syst Rev. 2014 Nov;11:CD010699.

    Google Scholar 

  34. Chadban S. Glomerulonephritis recurrence in the renal graft. J Am Soc Nephrol. 2001 Feb;12(2):394–402.

    CAS  PubMed  Google Scholar 

  35. Humar A, Lebranchu Y, Vincenti F, Blumberg EA, Punch JD, Limaye AP, et al. The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant. 2010 May;10(5):1228–37.

    Article  CAS  PubMed  Google Scholar 

  36. Kumar D. Immunizations following solid-organ transplantation. Curr Opin Infect Dis. 2014 Aug;27(4):329–35.

    Article  CAS  PubMed  Google Scholar 

  37. Kotton CN, Ryan ET, Fishman JA. Prevention of infection in adult travelers after solid organ transplantation. Am J Transplant. 2005 Jan;5(1):8–14.

    Article  PubMed  Google Scholar 

  38. Doycheva I, Amer S, Watt KD. De novo malignancies after transplantation: risk and surveillance strategies. Med Clin North Am. 2016 May;100(3):551–67.

    Article  PubMed  Google Scholar 

  39. Mittal A, Colegio OR. Skin cancers in organ transplant recipients. Am J Transplant. 2017 Oct;17(10):2509–30.

    Article  CAS  PubMed  Google Scholar 

  40. Karia PS, Azzi JR, Heher EC, Hills VM, Schmults CD. Association of sirolimus use with risk for skin cancer in a mixed-organ cohort of solid-organ transplant recipients with a history of cancer. JAMA Dermatol. 2016 May;152(5):533–40.

    Article  PubMed  Google Scholar 

  41. Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. NEJM. 2018 Feb;378(6):549–62.

    Article  CAS  PubMed  Google Scholar 

  42. Acuna SA, Huang JW, Scott AL, Micic S, Daly C, Brezden-Masley C, Kim SJ, Baxter NN. Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines. Am J Transplant. 2017 Jan;17(1):103–14.

    Article  CAS  PubMed  Google Scholar 

  43. McKay DB, Josephson MA, Armenti VT, August P, Coscia LA, Davis CL, et al. Reproduction and transplantation: report on the AST consensus conference on reproductive issues and transplantation. Am J Transplant. 2005 Jul;5(7):1592–9.

    Article  PubMed  Google Scholar 

  44. Josephson MA, McKay DB. Women and transplantation: fertility, sexuality, pregnancy, contraception. Adv Chronic Kidney Dis. 2013 Sept;20(5):433–40.

    Article  PubMed  Google Scholar 

  45. Zuber J, Anglicheau D, Elie C, Bererhi L, Timsit MO, Mamzer-Bruneel MF, Ciroldi M, et al. Sirolimus may reduced fertility in male renal transplant recipients. Am J Transplant. 2008 Jul;8(7):1471–9.

    Article  CAS  PubMed  Google Scholar 

  46. Constantinescu S, Pai A, Coscia L, Davison JM, Moritz MJ, Armenti VT. Breast-feeding after transplantation. Best Pract Res Clin Obstet Gynaecol. 2014 Nov;28(8):1163–73.

    Article  PubMed  Google Scholar 

  47. Potluri K, Hou S. Obesity in kidney transplant recipients and candidates. Am J Kidney Dis. 2010 Jul;56(1):143–56.

    Article  PubMed  Google Scholar 

  48. Sung RS, Althoen M, Howell TA, Ojo AO, Merion RM. Excess risk of renal allograft loss associated with cigarette smoking. Transplantation. 2001 Jun 27;71(12):1752–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA

    Heidi M. Schaefer

  2. Vanderbilt University Medical Center, Nashville, TN, USA

    Heidi M. Schaefer

Authors
  1. Heidi M. Schaefer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Heidi M. Schaefer .

Editor information

Editors and Affiliations

  1. Imperial College London, London, UK

    Nadey Hakim

  2. BaÅŸkent University, Ankara, Turkey

    Mehmet Haberal

  3. University of Virginia Medical Center, Charlottesville, VA, USA

    Daniel Maluf

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Schaefer, H.M. (2021). Long-Term Management of the Kidney Transplant Recipient. In: Hakim, N., Haberal, M., Maluf, D. (eds) Transplantation Surgery. Springer Specialist Surgery Series. Springer, Cham. https://doi.org/10.1007/978-3-030-55244-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-55244-2_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-55243-5

  • Online ISBN: 978-3-030-55244-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation